U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H22FN3O
Molecular Weight 375.4387
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ELOPIPRAZOLE

SMILES

FC1=CC=C(C=C1)C2=CC=C(CN3CCN(CC3)C4=C5OC=CC5=CC=C4)N2

InChI

InChIKey=PGNHBJGIQAEIHD-UHFFFAOYSA-N
InChI=1S/C23H22FN3O/c24-19-6-4-17(5-7-19)21-9-8-20(25-21)16-26-11-13-27(14-12-26)22-3-1-2-18-10-15-28-23(18)22/h1-10,15,25H,11-14,16H2

HIDE SMILES / InChI

Molecular Formula C23H22FN3O
Molecular Weight 375.4387
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Elopiprazole [DU 29894 or 1-(7-benzofuranyl)-4-[[5-(4-fluorophenyl)-1-H-pyrrol-2yl]methyl]piperazine) is an antagonist at dopamine D2 and D3 receptors and an agonist at serotonin1A receptors. Elopiprazole development for the treatment of psychotic disorders has been discontinued.

CNS Activity

Originator

Approval Year

PubMed

Substance Class Chemical
Record UNII
419A0R564U
Record Status Validated (UNII)
Record Version